Blue Earth Diagnostics Stock

blueearthdiagnostics.comHealthcareFounded: 2014Funding to Date: $21.3MM

Blue Earth Diagnostics is a molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need.

Register for Details

For more details on financing and valuation for Blue Earth Diagnostics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Blue Earth Diagnostics.

Register Today

Team

Management Team

Jim Martin
Chief Financial Officer
David Gauden
Chief Scientific Officer
Kathy Nagle Ph.D
Head of Manufacture/Supply Chain and Quality Assurance
Jonathan Allis Ph.D
Co-Founder, Board Member & Chief Executive Officer
Matthew Miller Ph.D
Head of Imaging and Project Management
Martin Murphy Ph.D
Chairman
Michael Heslop
President
Ted Broadbent Ph.D
Global Brand Director
Peter Gardiner
Chief Medical Officer

Board Members

Elisa Petris Ph.D
Syncona
Martin Murphy Ph.D
Jonathan Allis Ph.D

Other companies like Blue Earth Diagnostics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that a definitive agreement has been signed for Bracco Imaging S.p.A.